Untreated, Unresectable, or Metastatic Colorectal Cancer Clinical Trials in Chicago, Illinois

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer